Sandbox:Sahar: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 24: | Line 24: | ||
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| ECG view}} | ! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| ECG view}} | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC; " align="left"| Ventricular tachycardia<ref name="AjijolaTung2014">{{cite journal|last1=Ajijola|first1=Olujimi A.|last2=Tung|first2=Roderick|last3=Shivkumar|first3=Kalyanam|title=Ventricular tachycardia in ischemic heart disease substrates|journal=Indian Heart Journal|volume=66|year=2014|pages=S24–S34|issn=00194832|doi=10.1016/j.ihj.2013.12.039}}</ref><ref name="Meja LopezMalhotra2019">{{cite journal|last1=Meja Lopez|first1=Eliany|last2=Malhotra|first2=Rohit|title=Ventricular Tachycardia in Structural Heart Disease|journal=Journal of Innovations in Cardiac Rhythm Management|volume=10|issue=8|year=2019|pages=3762–3773|issn=21563977|doi=10.19102/icrm.2019.100801}}</ref><ref name="CoughtrieBehr2017">{{cite journal|last1=Coughtrie|first1=Abigail L|last2=Behr|first2=Elijah R|last3=Layton|first3=Deborah|last4=Marshall|first4=Vanessa|last5=Camm|first5=A John|last6=Shakir|first6=Saad A W|title=Drugs and life-threatening ventricular arrhythmia risk: results from the DARE study cohort|journal=BMJ Open|volume=7|issue=10|year=2017|pages=e016627|issn=2044-6055|doi=10.1136/bmjopen-2017-016627}}</ref><ref name="El-Sherif2001">{{cite journal|last1=El-Sherif|first1=Nabil|title=Mechanism of Ventricular Arrhythmias in the Long QT Syndrome: On Hermeneutics|journal=Journal of Cardiovascular Electrophysiology|volume=12|issue=8|year=2001|pages=973–976|issn=1045-3873|doi=10.1046/j.1540-8167.2001.00973.x}}</ref> | ! style="padding: 5px 5px; background: #DCDCDC; " align="left"| Ventricular tachycardia<ref name="AjijolaTung2014">{{cite journal|last1=Ajijola|first1=Olujimi A.|last2=Tung|first2=Roderick|last3=Shivkumar|first3=Kalyanam|title=Ventricular tachycardia in ischemic heart disease substrates|journal=Indian Heart Journal|volume=66|year=2014|pages=S24–S34|issn=00194832|doi=10.1016/j.ihj.2013.12.039}}</ref><ref name="Meja LopezMalhotra2019">{{cite journal|last1=Meja Lopez|first1=Eliany|last2=Malhotra|first2=Rohit|title=Ventricular Tachycardia in Structural Heart Disease|journal=Journal of Innovations in Cardiac Rhythm Management|volume=10|issue=8|year=2019|pages=3762–3773|issn=21563977|doi=10.19102/icrm.2019.100801}}</ref><ref name="CoughtrieBehr2017">{{cite journal|last1=Coughtrie|first1=Abigail L|last2=Behr|first2=Elijah R|last3=Layton|first3=Deborah|last4=Marshall|first4=Vanessa|last5=Camm|first5=A John|last6=Shakir|first6=Saad A W|title=Drugs and life-threatening ventricular arrhythmia risk: results from the DARE study cohort|journal=BMJ Open|volume=7|issue=10|year=2017|pages=e016627|issn=2044-6055|doi=10.1136/bmjopen-2017-016627}}</ref><ref name="El-Sherif2001">{{cite journal|last1=El-Sherif|first1=Nabil|title=Mechanism of Ventricular Arrhythmias in the Long QT Syndrome: On Hermeneutics|journal=Journal of Cardiovascular Electrophysiology|volume=12|issue=8|year=2001|pages=973–976|issn=1045-3873|doi=10.1046/j.1540-8167.2001.00973.x}}</ref><ref name="de RivaWatanabe2015">{{cite journal|last1=de Riva|first1=Marta|last2=Watanabe|first2=Masaya|last3=Zeppenfeld|first3=Katja|title=Twelve-Lead ECG of Ventricular Tachycardia in Structural Heart Disease|journal=Circulation: Arrhythmia and Electrophysiology|volume=8|issue=4|year=2015|pages=951–962|issn=1941-3149|doi=10.1161/CIRCEP.115.002847}}</ref> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*[[Ischemic heart disease]] | *[[Ischemic heart disease]] | ||
Line 85: | Line 85: | ||
*Hydrogen ions (Acidosis) | *Hydrogen ions (Acidosis) | ||
*Hypothermia | *Hypothermia | ||
* | *[[Electrolyte disturbances]] | ||
*Hypoglycemia | *Hypoglycemia | ||
*Tablets or Toxins (Drug overdose) such as beta blockers, tricyclic antidepressants, or calcium channel blockers | *Tablets or Toxins (Drug overdose) such as beta blockers, tricyclic antidepressants, or calcium channel blockers | ||
Line 101: | Line 101: | ||
[[File:Capture PEA.PNG|center|300px]] | [[File:Capture PEA.PNG|center|300px]] | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="left" | | ! style="padding: 5px 5px; background: #DCDCDC;" align="left" |Torsade de Pointes<ref name="pmid28674475">{{cite journal |vauthors=Li M, Ramos LG |title=Drug-Induced QT Prolongation And Torsades de Pointes |journal=P T |volume=42 |issue=7 |pages=473–477 |date=July 2017 |pmid=28674475 |pmc=5481298 |doi= |url=}}</ref><ref name="SharainMay2015">{{cite journal|last1=Sharain|first1=Korosh|last2=May|first2=Adam M.|last3=Gersh|first3=Bernard J.|title=Chronic Alcoholism and the Danger of Profound Hypomagnesemia|journal=The American Journal of Medicine|volume=128|issue=12|year=2015|pages=e17–e18|issn=00029343|doi=10.1016/j.amjmed.2015.06.051}}</ref><ref name="pmid11330748">{{cite journal |vauthors=Khan IA |title=Twelve-lead electrocardiogram of torsades de pointes |journal=Tex Heart Inst J |volume=28 |issue=1 |pages=69 |date=2001 |pmid=11330748 |pmc=101137 |doi= |url=}}</ref> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* | * *[[Electrolyte disturbances]] | ||
* Medications such as: | |||
** [[Amiodarone]] | |||
** [[Azithromycin ]] | |||
** [[Clozapine ]] | |||
**[[Famotidine]] | |||
** [[Flecainide ]] | |||
** [[Foscarnet ]] | |||
** [[Levofloxacin ]] | |||
** [[Lithium ]] | |||
** [[Mirtazipine]] | |||
** [[Quetiapine ]] | |||
** [[Risperidone ]] | |||
** [[Tacrolimus ]] | |||
** [[Tamoxifen ]] | |||
** [[Ziprasidone]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
# Paroxysms of VT with irregular RR intervals. | |||
# A ventricular rate between 200 and 250 beats per minute. | |||
# Two or more cycles of [[QRS complex]]es with alternating polarity. | |||
# Changing amplitude of the QRS complexes in each cycle in a sinusoidal fashion. | |||
# Prolongation of the [[QT interval]]. | |||
# Is often initiated by a [[PVC]] with a long coupling interval, R on T phenomenon. | |||
# There are usually 5 to 20 complexes in each cycle. | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
[[File:Capture Tors De P.PNG|center|300px]] | |||
|} | |} | ||
<references /> | <references /> |
Revision as of 20:58, 28 January 2020
Images
- Macura, Katarzyna J., Corl, Frank M., Fishman, Elliot K., Bluemke, David A. Pathogenesis in Acute Aortic Syndromes: Aortic Dissection, Intramural Hematoma, and Penetrating Atherosclerotic Aortic Ulcer. Am. J. Roentgenol. 2003 181: 309-316.
- Gomez-Jorge, Jackeline. E-medicine rads article
Disease Name | Causes | ECG Characteristics | ECG view |
---|---|---|---|
Ventricular tachycardia[1][2][3][4][5] |
|
||
Ventricular fibrillation[6][7][8][9] |
|
|
|
Asystole[10][11] |
|
||
Pulseless electrical activity[12][13] |
|
|
|
Torsade de Pointes[14][15][16] |
|
- ↑ Ajijola, Olujimi A.; Tung, Roderick; Shivkumar, Kalyanam (2014). "Ventricular tachycardia in ischemic heart disease substrates". Indian Heart Journal. 66: S24–S34. doi:10.1016/j.ihj.2013.12.039. ISSN 0019-4832.
- ↑ Meja Lopez, Eliany; Malhotra, Rohit (2019). "Ventricular Tachycardia in Structural Heart Disease". Journal of Innovations in Cardiac Rhythm Management. 10 (8): 3762–3773. doi:10.19102/icrm.2019.100801. ISSN 2156-3977.
- ↑ Coughtrie, Abigail L; Behr, Elijah R; Layton, Deborah; Marshall, Vanessa; Camm, A John; Shakir, Saad A W (2017). "Drugs and life-threatening ventricular arrhythmia risk: results from the DARE study cohort". BMJ Open. 7 (10): e016627. doi:10.1136/bmjopen-2017-016627. ISSN 2044-6055.
- ↑ El-Sherif, Nabil (2001). "Mechanism of Ventricular Arrhythmias in the Long QT Syndrome: On Hermeneutics". Journal of Cardiovascular Electrophysiology. 12 (8): 973–976. doi:10.1046/j.1540-8167.2001.00973.x. ISSN 1045-3873.
- ↑ de Riva, Marta; Watanabe, Masaya; Zeppenfeld, Katja (2015). "Twelve-Lead ECG of Ventricular Tachycardia in Structural Heart Disease". Circulation: Arrhythmia and Electrophysiology. 8 (4): 951–962. doi:10.1161/CIRCEP.115.002847. ISSN 1941-3149.
- ↑ Koplan BA, Stevenson WG (March 2009). "Ventricular tachycardia and sudden cardiac death". Mayo Clin. Proc. 84 (3): 289–97. doi:10.1016/S0025-6196(11)61149-X. PMC 2664600. PMID 19252119.
- ↑ Maury P, Sacher F, Rollin A, Mondoly P, Duparc A, Zeppenfeld K, Hascoet S (May 2017). "Ventricular arrhythmias and sudden death in tetralogy of Fallot". Arch Cardiovasc Dis. 110 (5): 354–362. doi:10.1016/j.acvd.2016.12.006. PMID 28222965.
- ↑ Saumarez RC, Camm AJ, Panagos A, Gill JS, Stewart JT, de Belder MA, Simpson IA, McKenna WJ (August 1992). "Ventricular fibrillation in hypertrophic cardiomyopathy is associated with increased fractionation of paced right ventricular electrograms". Circulation. 86 (2): 467–74. doi:10.1161/01.cir.86.2.467. PMID 1638716.
- ↑ Bektas, Firat; Soyuncu, Secgin (2012). "Hypokalemia-induced Ventricular Fibrillation". The Journal of Emergency Medicine. 42 (2): 184–185. doi:10.1016/j.jemermed.2010.05.079. ISSN 0736-4679.
- ↑ ACLS: Principles and Practice. p. 71-87. Dallas: American Heart Association, 2003. ISBN 0-87493-341-2.
- ↑ ACLS for Experienced Providers. p. 3-5. Dallas: American Heart Association, 2003. ISBN 0-87493-424-9.
- ↑ "2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care - Part 7.2: Management of Cardiac Arrest." Circulation 2005; 112: IV-58 - IV-66.
- ↑ Foster B, Twelve Lead Electrocardiography, 2nd edition, 2007
- ↑ Li M, Ramos LG (July 2017). "Drug-Induced QT Prolongation And Torsades de Pointes". P T. 42 (7): 473–477. PMC 5481298. PMID 28674475.
- ↑ Sharain, Korosh; May, Adam M.; Gersh, Bernard J. (2015). "Chronic Alcoholism and the Danger of Profound Hypomagnesemia". The American Journal of Medicine. 128 (12): e17–e18. doi:10.1016/j.amjmed.2015.06.051. ISSN 0002-9343.
- ↑ Khan IA (2001). "Twelve-lead electrocardiogram of torsades de pointes". Tex Heart Inst J. 28 (1): 69. PMC 101137. PMID 11330748.
Disease Name | Age of Onset | Gender Preponderance | Signs/Symptoms | Imaging Feature(s) | Macroscopic Feature(s) | Microscopic Feature(s) | Laboratory Findings(s) | Other Feature(s) | ECG view |
---|---|---|---|---|---|---|---|---|---|